Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Cerilliant
Teva
McKesson
Fuji
Dow
Boehringer Ingelheim
Chinese Patent Office

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SUBOXONE

« Back to Dashboard

Clinical Trials for Suboxone

Trial ID Title Status Sponsor Phase Summary
NCT00000320 Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Completed National Institute on Drug Abuse (NIDA) Phase 1/Phase 2 The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."
NCT00078117 Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 Completed University of California, Los Angeles Phase 3 The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.
NCT00249574 Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 Unknown status Organization to Achieve Solutions in Substance Abuse (OASIS) N/A The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
NCT00249574 Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 Unknown status National Institute on Drug Abuse (NIDA) N/A The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
NCT00367302 Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release Completed National Institute on Drug Abuse (NIDA) Phase 1/Phase 2 The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.
NCT00367302 Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release Completed New York City Department of Health and Mental Hygiene Phase 1/Phase 2 The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Suboxone

Condition Name

Condition Name for Suboxone
Intervention Trials
Opioid Dependence 12
Opioid-related Disorders 10
Opiate Dependence 8
Opiate Addiction 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Suboxone
Intervention Trials
Opioid-Related Disorders 28
Substance-Related Disorders 10
Behavior, Addictive 4
Disease 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Suboxone

Trials by Country

Trials by Country for Suboxone
Location Trials
United States 148
Norway 5
Canada 5
Taiwan 3
Austria 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Suboxone
Location Trials
New York 13
Maryland 12
Florida 11
California 10
Texas 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Suboxone

Clinical Trial Phase

Clinical Trial Phase for Suboxone
Clinical Trial Phase Trials
Phase 4 17
Phase 3 13
Phase 2/Phase 3 2
[disabled in preview] 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Suboxone
Clinical Trial Phase Trials
Completed 36
Recruiting 11
Active, not recruiting 7
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Suboxone

Sponsor Name

Sponsor Name for Suboxone
Sponsor Trials
National Institute on Drug Abuse (NIDA) 19
Indivior Inc. 15
Johns Hopkins University 7
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Suboxone
Sponsor Trials
Other 64
Industry 31
NIH 21
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fuji
Cipla
Chubb
Julphar
Daiichi Sankyo
Queensland Health
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.